ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,209Medicare Part D Prescriptions Filled, Including Refills

Rank: 78 out of 663

$413K Total Retail Price of All Prescriptions

Rank: 122 out of 663

764 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Colorado
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 764 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

10% of this provider’s 764 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 8,870 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Colorado
SIMVASTATIN 925 891 1 1
LISINOPRIL 545 541 2 2
OMEPRAZOLE 384 366 3 4
ATENOLOL 354 340 4 10
HYDROCHLOROTHIAZIDE 295 283 5 12
AMLODIPINE BESYLATE 293 290 6 5
METOPROLOL TARTRATE 248 244 7 11
WARFARIN SODIUM 238 236 8 8
LEVOTHROID 236 231 9 19
HYDROCODONE-ACETAMINOPHEN 200 193 S3 10 6
TERAZOSIN HCL 179 173 11 38
LEVOTHYROXINE SODIUM 175 171 12 3
CITALOPRAM HBR 175 173 12 18
ZOLPIDEM TARTRATE 175 154 12 16
LOSARTAN POTASSIUM 168 168 15 14
FLUTICASONE PROPIONATE 166 146 16 27
ALENDRONATE SODIUM 160 157 17 15
GLIPIZIDE 152 147 18 29
METFORMIN HCL 148 144 19 9
PREDNISONE 130 125 20 39
FLUOXETINE HCL 130 117 20 32
RANITIDINE HCL 128 127 22 31
ATORVASTATIN CALCIUM 120 120 23 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 111 98 24 22
ALLOPURINOL 111 111 24 28
TAMSULOSIN HCL 107 106 26 24
K-TAB 104 98 27 36
OXYCODONE-ACETAMINOPHEN 99 90 S2 28 26
PRAVASTATIN SODIUM 95 92 29 21
NOVOLIN N 95 90 29 44
FUROSEMIDE 90 90 31 7
TRIAMTERENE-HYDROCHLOROTHIAZID 87 87 32 49
NORTRIPTYLINE HCL 74 71 33 63
ESTRADIOL 72 70 R 34 66
DILT-XR 68 68 35 100
INSULIN SYRINGE 67 65 36 55
PROAIR HFA 58 53 37 33
TRAMADOL HCL 58 54 37 17
MIRTAZAPINE 56 56 39 52
CLOPIDOGREL 56 53 39 65
FINASTERIDE 50 49 41 56
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.